35 of 38 analysts maintain a buy rating
As the year closes, some of the world's most influential investment banks have turned their gaze toward three distinct corners of the Indian economy — commodity exchange infrastructure, non-bank lending, and defense electronics — and found in each a story grounded not in hope but in measurable change. Morgan Stanley's near-doubling of its MCX target, a global banking consortium's conviction in Shriram Finance following a transformative Japanese capital infusion, and Goldman Sachs' steady faith in Bharat Electronics' swelling order book together suggest that India's economic momentum is being validated from the outside in. These are not speculative bets but calibrated responses to shifting fundamentals — rising transaction volumes, strengthened balance sheets, and thickening defense pipelines — each a signal that structural tailwinds are being taken seriously at the highest levels of global finance.
- Morgan Stanley nearly doubled its MCX price target to ₹11,135, reversing an underweight stance as commodity trading volumes surge and daily transaction revenues climb with no clear ceiling in sight.
- Shriram Finance has become a rare consensus trade — 35 of 38 analysts hold a buy rating — after MUFG's ₹40,000 crore stake acquisition promised to nearly double the company's Tier-1 capital and slash its leverage ratio.
- A cascade of AAA credit upgrades, including one just this week on its fixed deposit program, is expected to cut Shriram Finance's cost of funds by 100 basis points over two years, compressing costs while expanding margins.
- Goldman Sachs is holding firm on Bharat Electronics at ₹455, pointing to ₹1,350 crore in December orders alone and a full-year inflow guidance of ₹27,000 crore as evidence that India's defense spending cycle is far from exhausted.
- Morgan Stanley's broader sweep across Indian financials — raising targets on SBI Life and Can Fin Homes, upgrading the latter to overweight — signals a sector-wide reassessment rather than isolated stock calls.
Wall Street and Mumbai's major brokerages ended the year with a decisive turn toward three pillars of the Indian economy, each upgrade anchored in hard data rather than sentiment. Morgan Stanley's reversal on MCX was the most dramatic: the bank moved from underweight to equal-weight and nearly doubled its price target to ₹11,135, citing a sharp climb in average daily transaction revenue over the past three months. Volatile commodity prices have driven trading activity higher, and the bank sees that energy persisting — raising earnings estimates and acknowledging further upside if volumes hold.
Shriram Finance drew the broadest analyst consensus, with Nomura, Jefferies, and CLSA all maintaining buy ratings and price targets ranging from ₹1,030 to ₹1,200. The catalyst was structural: Japan's MUFG Bank agreed to acquire a 20 percent stake for roughly ₹40,000 crore, a deal that is expected to lift Tier-1 capital from 20 percent to around 33 percent and reduce leverage to nearly three times. Credit rating agencies responded swiftly, upgrading the company to CARE AAA across multiple instruments, with the fixed deposit program receiving the same designation just this week. Jefferies projects a 100 basis point drop in cost of funds over two years, lifting earnings estimates for fiscal 2027 and 2028 by 5 to 7 percent. Nomura sees return on assets reaching 3.9 percent by fiscal 2028, while CLSA forecasts assets under management growing at an 18 to 20 percent compound annual rate.
In defense, Goldman Sachs held its buy rating on Bharat Electronics at ₹455, pointing to ₹1,350 crore in December orders and a full-year inflow guidance of ₹27,000 crore. The bank flagged the fourth-quarter pipeline as the critical variable for hitting that target, but the broader message was clear: BEL's order book is deep and revenue visibility is improving.
Morgan Stanley also adjusted its broader financial services coverage, raising SBI Life's target to ₹2,460, upgrading Can Fin Homes to overweight at ₹1,060, and lifting L&T Finance's target to ₹160 despite maintaining caution on the stock. Taken together, the pattern across these calls reflects a market that has found conviction in commodity volatility as a structural tailwind, capital infusion as a growth accelerant in lending, and defense spending as a durable source of order flow — each thesis resting on observable facts rather than optimism alone.
Wall Street and Mumbai's major brokerages have turned decisively bullish on three pillars of the Indian economy this week, each for distinct reasons rooted in hard momentum. Morgan Stanley's shift on MCX—from underweight to equal-weight, with a target price nearly doubled to ₹11,135—signals confidence that the commodity exchange's surge in trading activity will hold. The driver is straightforward: average daily transaction revenue has climbed sharply over the past three months, fueled by volatile commodity prices, and the bank sees no reason for that energy to dissipate soon. The upgrade comes with materially raised earnings estimates and acknowledgment of upside risk if transaction volumes remain elevated.
Shriram Finance, India's second-largest retail non-bank lender, has become a consensus darling among global analysts. Nomura, Jefferies, and CLSA all maintain buy ratings, with price targets spanning ₹1,030 to ₹1,200—a range that reflects genuine conviction rather than scattered opinion. The catalyst is concrete: Japan's MUFG Bank agreed in recent weeks to acquire a 20 percent stake for roughly ₹40,000 crore, a transaction that fundamentally reshapes the company's balance sheet. Tier-1 capital is expected to climb to around 33 percent from 20 percent. Leverage should fall to nearly 3 times. On the heels of that deal, credit rating agencies upgraded Shriram Finance to the highest category—CARE AAA with stable outlook—across multiple debt instruments. Just this week, CARE assigned that same AAA rating to the company's fixed deposit program, a move that opens doors to cheaper funding and attracts risk-averse savers.
Jefferies projects that Shriram Finance's cost of funds will drop by 100 basis points over the next two years, allowing the company to expand net interest margins even as it passes some savings to borrowers. The bank has lifted earnings estimates for fiscal 2027 and 2028 by 5 to 7 percent and expects credit costs to run 10 to 20 basis points lower than previously modeled. Nomura forecasts return on assets of 3.9 percent by fiscal 2028, moderating to 3.7 percent thereafter. CLSA sees assets under management growing at an 18 to 20 percent compound annual rate. The analyst consensus is overwhelming: 35 of 38 analysts covering the stock maintain a buy rating.
In the defense sector, Goldman Sachs has held firm with a buy rating on Bharat Electronics at ₹455 per share, citing order momentum that shows no signs of weakening. The company landed ₹1,350 crore in fresh orders during December alone. Goldman's full-year order inflow guidance sits at ₹27,000 crore, and the bank emphasizes that the fourth-quarter order pipeline will be critical to hitting that target. The message is clear: BEL's order book is thick, revenue visibility is improving, and the company has runway to grow.
Beyond these three names, Morgan Stanley has also adjusted its stance on other financial services plays. SBI Life received a target price hike to ₹2,460 from ₹2,310, with the bank rolling over its valuation framework to March 2027. Can Fin Homes was upgraded to overweight with a target of ₹1,060, up from ₹1,000. L&T Finance saw its target raised to ₹160 from ₹143 despite maintaining an underweight rating, reflecting higher earnings estimates even as the bank remains cautious on the stock. Manappuram Finance holds at equal-weight with a ₹300 target, though consolidated earnings estimates have been trimmed.
The pattern across these upgrades reflects a market that has found conviction in three distinct narratives: commodity volatility as a structural tailwind, financial services consolidation and capital infusion as a growth accelerant, and defense spending as a durable source of order flow. Each story rests on observable facts—transaction volumes, balance sheet metrics, order books—rather than sentiment or hope. For investors watching these sectors, the message from the world's largest investment banks is that the fundamentals have shifted in a way that justifies higher valuations.
Notable Quotes
Strong momentum in average daily transaction revenue over three months, with no expectation of near-term decline— Morgan Stanley on MCX
Cost of funds expected to drop by 100 basis points over the next two years, with net interest margins expanding— Jefferies on Shriram Finance
The Hearth Conversation Another angle on the story
Why does Morgan Stanley think MCX's trading surge will actually stick around? Isn't volatility by definition temporary?
The bank isn't betting on volatility itself to persist—it's betting that the structural shift in how much people are trading commodities has legs. When you see three months of elevated transaction revenue, you're seeing a change in behavior, not just a spike. The commodity markets are deeper and more active than they were.
And Shriram Finance—is the MUFG deal really that transformative, or is it just capital?
It's both, but the capital is the visible part. What matters more is that a global bank with MUFG's reputation just validated the business model by writing a ₹40,000 crore check. That changes how other lenders and depositors see the company. The credit rating upgrade follows because the balance sheet is genuinely stronger.
The analysts are nearly unanimous on Shriram—35 of 38 buy ratings. Doesn't that feel crowded?
It does, but it's also rational. When a company's leverage drops, its funding costs fall, and its capital position strengthens all at once, the math points the same direction for everyone. The question isn't whether the analysts are right—it's whether the stock price has already priced in all of it.
What about BEL? Defense orders sound good, but how real is that ₹27,000 crore guidance?
Goldman Sachs is tying the rating to the order pipeline, not to revenue already booked. That's a meaningful distinction. The company has to convert those orders into actual deliveries and cash. But ₹1,350 crore in December orders suggests the pipeline is real.
If all three of these stories are true, what's the risk?
Execution. MCX needs volumes to stay high. Shriram Finance needs to actually lower its cost of funds and grow assets. BEL needs to deliver on those orders. Any one of those could stumble.